{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:04:02Z","timestamp":1793822642434,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neurobiolaging.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T11:12:22Z","timestamp":1611400342000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["KL\u2217VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE\u22174 carriers"],"prefix":"10.1016","volume":"101","author":[{"given":"Michael E.","family":"Belloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Eger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-8364","authenticated-orcid":false,"given":"Yann","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4378-6838","authenticated-orcid":false,"given":"Valerio","family":"Napolioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie D.","family":"Deters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia A.","family":"Scelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenielle","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Naomi","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth C.","family":"Mormino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihuai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer S.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Greicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.022484299","article-title":"Association of human aging with a functional variant of klotho","volume":"99","author":"Arking","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib2","first-page":"164","article-title":"Enrichment factors for clinical trials in mild-to-moderate Alzheimer\u2019s disease","volume":"5","author":"Ballard","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib3","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A\u00a0quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","article-title":"Association of klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4","volume":"77","author":"Belloy","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: a longitudinal study","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib7","first-page":"272","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroimage.2015.03.069","article-title":"Harvard aging brain study: dataset and accessibility","volume":"144","author":"Dagley","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.celrep.2014.03.076","article-title":"Life extension factor klotho enhances cognition","volume":"7","author":"Dubal","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int. Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib11","doi-asserted-by":"crossref","first-page":"e1878","DOI":"10.1212\/WNL.0000000000007323","article-title":"KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD","volume":"92","author":"Erickson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","article-title":"The ADNI PET core: 2015","volume":"11","author":"Jagust","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib17","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fnagi.2017.00353","article-title":"Neuroprotective effect of ligustilide through induction of \u03b1-secretase processing of both APP and Klotho in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Kuang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1112766","article-title":"Suppression of aging in mice by the hormone Klotho","volume":"309","author":"Kurosu","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","article-title":"Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers","volume":"41","author":"Landau","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-017-0846-x","article-title":"Study protocol: Insight 46 \u2013 a neuroscience sub-study of the MRC National Survey of Health and Development","volume":"17","author":"Lane","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib22","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1073\/pnas.1012568107","article-title":"Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","article-title":"Amyloid and APOE e4 interact to influence short-term decline in preclinical Alzheimer disease","volume":"82","author":"Mormino","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3233\/JAD-180788","article-title":"An UNC5C allele predicts cognitive decline and hippocampal atrophy in clinically normal older adults","volume":"68","author":"Yang","year":"2019","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11682-016-9598-2","article-title":"Systemic klotho is associated with KLOTHO variation and predicts intrinsic cortical connectivity in healthy human aging","volume":"11","author":"Yokoyama","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acn3.161","article-title":"Variation in longevity gene KLOTHO is associated with greater cortical volumes","volume":"2","author":"Yokoyama","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.008_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2019.02.003","article-title":"Lentiviral vector\u2013mediated overexpression of Klotho in the brain improves Alzheimer\u2019s disease\u2013like pathology and cognitive deficits in mice","volume":"78","author":"Zeng","year":"2019","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:36:59Z","timestamp":1759318619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"alternative-id":["S0197458021000154"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KL\u2217VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE\u22174 carriers","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}